Cost-effectiveness of viral load testing for transitioning antiretroviral therapy-experienced children to dolutegravir in South Africa: a modelling analysis

The Eunice Kennedy Shriver Institute for Child Health and Human Development, the National Institute of Allergy and Infectious Diseases, the Massachusetts General Hospital Executive Committee on Research, the Massachusetts General Hospital, and the Medical Research Council.

Authors

Institutions

Publication Details

Journal
The Lancet Global Health
Published
2024-11-20
DOI
https://doi.org/10.1016/s2214-109x(24)00381-4
Citations
1
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cost-effectiveness of viral load testing for transitioning antiretroviral therapy-experienced children to dolutegravir in South Africa: a modelling analysis

Martina Penazzato, Jason Bacha, Mary‐Ann Davies, Siobhan Crichton et al.
1 citations
The Lancet Global Health
HIV/AIDS drug development and treatment
0.39
article

Cost-effectiveness of viral load testing for transitioning antiretroviral therapy-experienced children to dolutegravir in South Africa: a modelling analysis

Martina Penazzato, Jason Bacha, Mary‐Ann Davies, Siobhan Crichton, Karen Webb, Sophie Desmonde, Clare Flanagan, Anne M. Neilan, Intira Jeannie Collins, Elaine J. Abrams, Emily P. Hyle, S. Horsfall, Isaac Ravi Brenner, Andrea Ciaranello, Kenneth A Freedberg
article en
1 citations

Abstract

The Eunice Kennedy Shriver Institute for Child Health and Human Development, the National Institute of Allergy and Infectious Diseases, the Massachusetts General Hospital Executive Committee on Research, the Massachusetts General Hospital, and the Medical Research Council.

The Lancet Global HealthVol. 12(12)
Massachusetts General Hospital (US), MRC Clinical Trials Unit at UCL (GB), University College London (GB)
Massachusetts General Hospital, Gilead Sciences, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, ViiV Healthcare, National Institutes of Health, Medical Research Council, National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development
Openalex Percentile: Top 35%
HIV/AIDS drug development and treatment
0.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.